Champions TumorGraft™ Database

Welcome to the Champions Oncology TumorGraft™ Database. This restricted access database contains detailed clinical, molecular, and genetic characterization data on Champions’ TumorGraft™ models. The database is updated on a regular basis with new models and characterization data. If you already have an account, please log in below.

Forgot your password?

Request access to the TumorGraft™ database.

You may also contact [email protected] with any questions.

References:

  1. Hidalgo M et al. Activity of gemcitabine in direct patient derived xenografts predicts clinical outcome: validation of an in vivo model for drug development. J Clin Oncol 27:15s, 2009 (suppl; abstr 4528)
  2. Hidalgo M et al. A Pilot Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer. Mol Cancer Ther August 2011 10:1311-1316
  3. Rubio-Viqueira B, Jimeno A, Cusatis G, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12:4652-4661.
  4. Champions data on file.